• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session

    11/22/22 1:16:51 PM ET
    $A
    $AENZ
    $AEO
    $AGBA
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Engineering & Construction
    Industrials
    Get the next $A alert in real time by email

    Gainers

    • Palisade Bio, Inc. (NASDAQ:PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel function following surgery.
    • Cosmos Holdings Inc. (NASDAQ:COSM) rose 52% to $0.2656 after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on Iberian Airlines' in-flight magazine, Ronda.
    • Aenza S.A.A. (NYSE:AENZ) gained 42.3% to $3.49.
    • ObsEva SA (NASDAQ:OBSV) shares climbed 31.3% to $0.2175 after the company reported the sale of Ebopiprant license agreement to XOMA for up to $113 million.
    • Bonso Electronics International Inc. (NASDAQ:BNSO) shares climbed 30.5% to $4.0532.
    • FOXO Technologies Inc. (NYSE:FOXO) jumped 23% to $0.6001. Foxo Technologies, said effective November 14, 2022, Jon Sabes has been terminated as CEO and Chairman of board of company.
    • Grindr Inc. (NYSE:GRND) gained 21.3% to $23.91 after dropping 46% on Monday.
    • Charah Solutions, Inc. (NYSE:CHRA) jumped 21.1% to $1.0628. Charah Solutions recently reported mixed Q3 results.
    • Cingulate Inc. (NASDAQ:CING) gained 20.3% to $0.8313. Maxim Group initiated coverage on Cingulate with a Buy rating and announced a price target of $3.
    • Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) surged 20.3% to $0.6743. Cyclerion said it concluded the unsolicited proposal received on November 20 was “not in the best interest of the company.”
    • Biodesix, Inc. (NASDAQ:BDSX) jumped 20% to $1.5600. Biodesix 10% owner Jack Schuler acquired a total of 8,695,652 shares at an average price of $1.15.
    • WW International, Inc. (NASDAQ:WW) gained 17.4% to $4.2650. Sima Sistani, Chief Executive Officer at WW International, reported a large insider buy on November 21, according to a new SEC filing.
    • Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) rose 17.3% to $0.6571 after gaining around 8% on Monday.
    • American Eagle Outfitters, Inc. (NYSE:AEO) gained 16.5% to $15.15 after the company reported better-than-expected Q3 GAAP EPS and sales results.
    • Burlington Stores, Inc. (NYSE:BURL) jumped 16.4% to $183.55 after the company reported Q3 financial results and issued guidance.
    • Draganfly Inc. (NASDAQ:DPRO) gained 15.3% to $1.06. Draganfly has been selected by PromoDrone to provide its Public Safety technology to the PromoDrone platform for Emergency Management.
    • Elevation Oncology, Inc. (NASDAQ:ELEV) rose 15.2% to $1.08.
    • Warner Music Group Corp. (NASDAQ:WMG) jumped 14.8% to $30.99. Warner Music Group reported fourth-quarter FY22 revenue growth of 8.8% year-on-year to $1.497 billion, beating the consensus of $1.42 billion.
    • Abercrombie & Fitch Co. (NYSE:ANF) gained 14.8% to $21.38 after the company reported better-than-expected Q3 EPS and sales results.
    • TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) jumped 11.4% to $1.3824. TFF Pharmaceuticals recently priced a $10.675 million offering of common stock and warrants.
    • Best Buy Co., Inc. (NYSE:BBY) gained 11.2% to $78.77 after the company reported better-than-expected Q3 EPS and sales results.
    • Maximus, Inc. (NYSE:MMS) surged 9.6% to $66.35 after the company reported better-than-expected Q4 EPS and sales results. The company also issued FY23 EPS and sales guidance above analyst estimates.
    • Angel Pond Holdings Corporation (NYSE:POND) gained 9% to $10.63.
    • Nexalin Technology, Inc. (NASDAQ:NXL) rose 8.2% to $2.2192 after surging around 14% on Monday.
    • Agilent Technologies, Inc. (NYSE:A) gained 6.7% to $154.95 after the company reported better-than-expected Q4 EPS and sales results.
    • First Wave BioPharma, Inc. (NASDAQ:FWBI) rose 6.3% to $0.7219. First Wave BioPharma reported a private placement.

     

    Losers

    • Eqonex Limited (NASDAQ:EQOS) fell 27.9% to $0.1514 after dipping around 24% on Monday.
    • Perfect Corp. (NYSE:PERF) fell 22% to $6.75. Goldman Sachs, on Monday, initiated coverage on Perfect with a Neutral rating and announced a price target of $7.8.
    • Agora, Inc. (NASDAQ:API) dropped 21% to $2.6450 after the company posted downbeat Q3 results and issued weak FY22 sales forecast.
    • Actinium Pharmaceuticals, Inc. (NYSE:ATNM) declined 19.9% to $9.44.
    • MacroGenics, Inc. (NASDAQ:MGNX) shares tumbled 18.9% to $5.16 after Cowen & Co. downgraded the stock from Outperform to Market Perform.
    • VIQ Solutions Inc. (NASDAQ:VQS) fell 17.8% to $0.2547.
    • GDS Holdings Limited (NASDAQ:GDS) dipped 17.1% to $11.45.
    • EUDA Health Holdings Limited (NASDAQ:EUDA) fell 16.9% to $3.14 after dipping 15% on Monday.
    • Jack in the Box Inc. (NASDAQ:JACK) fell 16.4% to $70.98 after the company issued soft FY23 guidance.
    • Mesa Laboratories, Inc. (NASDAQ:MLAB) declined 15.7% to $155.25 after the company announced its Clinical Genomics Division customer, Sema4, will exit the reproductive health screening business. Sema4 informed the company it will reduce the quantity of orders in Q3.
    • Dycom Industries, Inc. (NYSE:DY) fell 15.5% to $92.63 after the company reported Q3 earnings results.
    • WiSA Technologies, Inc. (NASDAQ:WISA) dropped 14.8% to $0.22.
    • Hillstream BioPharma, Inc. (NASDAQ:HILS) shares fell 14.7% to $0.4004 in pre-market trading after jumping 10% on Monday.
    • Noah Holdings Limited (NYSE:NOAH) dipped 14.4% to $12.80 following Q3 results.
    • iQIYI, Inc. (NASDAQ:IQ) fell 13.8% to $2.4450 following Q3 results.
    • Satixfy Communications Ltd. (NYSE:SATX) dropped 13.4% to $26.98.
    • Gamida Cell Ltd. (NASDAQ:GMDA) fell 12.8% to $1.5525 after the company issued a regulatory update on Omidubicel. The company said it received extension of Omidubicel PDUFA Date from Jan. 30, 2023 to May 1, 2023 as the FDA issued information request.
    • Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) dropped 12.5% to $2.16.
    • Construction Partners, Inc. (NASDAQ:ROAD) fell 11.8% to $28.65 after reporting Q4 results.
    • AGBA Group Holding Limited (NASDAQ:AGBA) fell 11.7% to $5.58. AGBA Acquisition Limited recently completed its business combination with TAG Holdings Limited.
    • Movado Group, Inc. (NYSE:MOV) dropped 11% to $29.81 after the company posted downbeat quarterly sales and lowered FY23 sales forecast.
    • Central Garden & Pet Company (NASDAQ:CENTA) dipped 10.6% to $37.50 following weak quarterly results.
    • Dollar Tree, Inc. (NASDAQ:DLTR) fell 9.9% to $148.97 after the company reported Q3 earnings results.
    • Siyata Mobile Inc. (NASDAQ:SYTA) fell 9.1% to $0.1765 after jumping 26% on Monday.
    • Canoo Inc. (NASDAQ:GOEV) fell 9.1% to $1.0550. The company recently posted a narrower-than-expected quarterly loss.
    • Chico's FAS, Inc. (NYSE:CHS) dropped 6.7% to $6.64 after the company issued weak Q4 forecast.
    • Zoom Video Communications, Inc. (NASDAQ:ZM) fell 6% to $75.49 after the company reported better-than-expected results, but issued weak guidance.
    Get the next $A alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $A
    $AENZ
    $AEO
    $AGBA

    CompanyDatePrice TargetRatingAnalyst
    Best Buy Co. Inc.
    $BBY
    4/13/2026$59.00Buy → Sell
    Goldman
    MacroGenics Inc.
    $MGNX
    4/10/2026$9.00Neutral → Buy
    B. Riley Securities
    Palisade Bio Inc.
    $PALI
    4/9/2026$7.00Outperform
    Wolfe Research
    Construction Partners Inc.
    $ROAD
    4/3/2026$135.00Neutral → Buy
    B. Riley Securities
    Construction Partners Inc.
    $ROAD
    4/2/2026$135.00Neutral → Buy
    B. Riley Securities
    Palisade Bio Inc.
    $PALI
    3/26/2026$7.00Buy
    H.C. Wainwright
    American Eagle Outfitters Inc.
    $AEO
    3/26/2026Hold
    Needham
    Abercrombie & Fitch Company
    $ANF
    3/26/2026$108.00Buy
    Needham
    More analyst ratings

    $A
    $AENZ
    $AEO
    $AGBA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Best Buy downgraded by Goldman with a new price target

    Goldman downgraded Best Buy from Buy to Sell and set a new price target of $59.00

    4/13/26 8:42:52 AM ET
    $BBY
    Consumer Electronics/Video Chains
    Consumer Discretionary

    MacroGenics upgraded by B. Riley Securities with a new price target

    B. Riley Securities upgraded MacroGenics from Neutral to Buy and set a new price target of $9.00

    4/10/26 8:27:02 AM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Wolfe Research initiated coverage on Palisade Bio with a new price target

    Wolfe Research initiated coverage of Palisade Bio with a rating of Outperform and set a new price target of $7.00

    4/9/26 8:43:44 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $A
    $AENZ
    $AEO
    $AGBA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ladiwala Shiraz Shabanali bought $252,805 worth of shares (3,500 units at $72.23), increasing direct ownership by 70% to 8,523 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    3/10/26 5:43:24 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Director Capone Mark Christopher bought $99,331 worth of shares (1,301 units at $76.35), increasing direct ownership by 61% to 3,429 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    3/10/26 3:46:59 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Director Tripeny R Tony bought $99,940 worth of shares (1,315 units at $76.00), increasing direct ownership by 32% to 5,398 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    3/10/26 3:39:49 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $A
    $AENZ
    $AEO
    $AGBA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 18, 2024 - FDA Roundup: June 18, 2024

    For Immediate Release: June 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a request for input about patient safety associated with certain medical software functions excluded from the medical device definition. This input will help the FDA develop the 2024 report on the risks and benefits to health of non-devic

    6/18/24 3:16:28 PM ET
    $DLTR
    $AMGN
    Department/Specialty Retail Stores
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for MARGENZA issued to MACROGENICS INC

    Submission status for MACROGENICS INC's drug MARGENZA (SUPPL-5) with active ingredient MARGETUXIMAB-CMKB has changed to 'Approval' on 05/25/2023. Application Category: BLA, Application Number: 761150, Application Classification:

    5/29/23 4:45:45 AM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    April 17, 2023 - FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

    For Immediate Release: April 17, 2023 Today, the U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a subset of white blood cells) in the body and reduce the risk of infection. The product is intended for use in adults and pediatric patients 12 years and older with blood cancers p

    4/17/23 1:02:15 PM ET
    $GMDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $A
    $AENZ
    $AEO
    $AGBA
    SEC Filings

    View All

    SEC Form DEFA14A filed by MacroGenics Inc.

    DEFA14A - MACROGENICS INC (0001125345) (Filer)

    4/22/26 4:45:03 PM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Best Buy Co. Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - BEST BUY CO INC (0000764478) (Filer)

    4/22/26 7:01:15 AM ET
    $BBY
    Consumer Electronics/Video Chains
    Consumer Discretionary

    SEC Form DEFA14A filed by Abercrombie & Fitch Company

    DEFA14A - ABERCROMBIE & FITCH CO /DE/ (0001018840) (Filer)

    4/20/26 4:34:41 PM ET
    $ANF
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $A
    $AENZ
    $AEO
    $AGBA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by President and CEO Kadia Siddhartha

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    4/24/26 10:49:12 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    SEC Form 3 filed by new insider Kadia Siddhartha

    3 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    4/24/26 10:41:18 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    SEC Form 4 filed by Bawa Aparna

    4 - Zoom Communications, Inc. (0001585521) (Issuer)

    4/21/26 4:54:01 PM ET
    $ZM
    Computer Software: Programming Data Processing
    Technology

    $A
    $AENZ
    $AEO
    $AGBA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Buy Research Opinion on Zoom Communications (NASDAQ: ZM)

    NOTE TO EDITORS: The Following Is an Investment Opinion Issued by Spruce Point Capital Management Provides Evidence the Bear Thesis on Zoom Shares Does Not Hold Up to Scrutiny Believes Zoom's Transformation Into a Comprehensive, Value-Added, AI-First Platform Poised to Drive Deeper Enterprise Penetration is Underappreciated Demonstrates Zoom is Trading at a Massive Discount to Its Intrinsic Value, Particularly Considering Its Share Ownership in AI Leader Anthropic Identifies A Range of Cost Structure, Organizational Effectiveness, Capital Allocation Practices, and Corporate Governance Concerns For Zoom to Address Announces It Has Sent the Zoom Board of Directors a Letter Containin

    4/24/26 8:30:00 AM ET
    $ZM
    Computer Software: Programming Data Processing
    Technology

    iQIYI Returns to LVL UP EXPO 2026 in Las Vegas with Blacklyte, Debuting Peter Pau AI Theater and Immersive AI Experiences

    LAS VEGAS, April 24, 2026 /PRNewswire/ -- iQIYI International showcases AI-powered storytelling, Chinese anime, and VIP giveaways at the Las Vegas Convention Center on April 24–26, 2026, in partnership with premium Canadian immersive ecosystem brand, Blacklyte. Founded in 2010, iQIYI (NASDAQ:IQ) is one of Asia's largest online entertainment platforms, and iQIYI International, launched in 2019, now serves over 100 million users across 190+ territories with a user interface and subtitles in 13 languages.Experience the Future of AI StorytellingAt this year's LVL UP EXPO, iQIYI debu

    4/24/26 8:00:00 AM ET
    $IQ
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Elizabeth Moellering Named General Counsel and Corporate Secretary of Maximus

    Moellering has served as interim general counsel since February 2026 Maximus (NYSE:MMS), a leading provider of tech-enabled government services, today announced Elizabeth Moellering as the company's new General Counsel and Corporate Secretary. In this role, she succeeds John Martinez, who departed the company earlier this year. Since February of this year, Moellering has served as Interim General Counsel and Deputy General Counsel. She originally joined Maximus in 2024 as Head of Litigation, where she built a new, disciplined structure for managing legal disputes before taking on additional responsibilities. "The role of General Counsel is important to helping Maximus fulfill our miss

    4/24/26 6:00:00 AM ET
    $MMS
    Real Estate

    $A
    $AENZ
    $AEO
    $AGBA
    Leadership Updates

    Live Leadership Updates

    View All

    Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors

    NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced that it has appointed Heather Thiltgen to the Company's Board of Directors, effective April 20, 2026. Ms. Thiltgen currently serves as the President of Presbyterian Health Plan and previously served as President & CEO of WellSense Health Plan. As Weight Watchers expands its integrated weight health platform, Ms. Thiltgen brings decades of successful healthcare leadership experience with expertise in: Expanding coverage and access to GLP-1 therapies;Navigating complex regulatory environments, including

    4/20/26 7:30:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Zoom appoints Russell Dicker as chief product officer to advance AI-first product strategy and workflow automation

    SAN JOSE, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- Zoom Communications, Inc. (NASDAQ:ZM) today announced the appointment of Russell Dicker as the company's chief product officer (CPO), leading product strategy for Zoom's system of action, turning conversations into completed work through AI. Russell brings more than 25 years of experience building and scaling global product platforms, including leading Microsoft Teams' product and data science teams, with a focus on applying AI to simplify workflows and improve how work gets done. Russell joins Zoom at a pivotal time, as companies seek AI tools to automate processes and tasks, freeing up time for higher-level work. Zoom is uniquely posi

    4/15/26 9:05:00 AM ET
    $ZM
    Computer Software: Programming Data Processing
    Technology

    Agilent Showcases Cancer Research Solutions at AACR 2026

    Agilent Technologies Inc. (NYSE:A) will present new technologies, scientific collaborations, and integrated workflows supporting cancer research and diagnostics at the American Association for Cancer Research (AACR) Annual Meeting on April 17–22, 2026, in San Diego, California. At the meeting, Agilent will highlight advances designed to connect discovery research, translational science, and companion diagnostics development, reflecting the growing demand for more integrated approaches across the cancer research continuum. Among the technologies featured is the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation series of cell imaging and multimode micropla

    4/15/26 8:00:00 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $A
    $AENZ
    $AEO
    $AGBA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by iQIYI Inc.

    SC 13D/A - iQIYI, Inc. (0001722608) (Subject)

    12/4/24 8:11:53 AM ET
    $IQ
    Consumer Electronics/Video Chains
    Consumer Discretionary

    SEC Form SC 13G filed by MacroGenics Inc.

    SC 13G - MACROGENICS INC (0001125345) (Subject)

    11/20/24 10:44:27 AM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by TFF Pharmaceuticals Inc.

    SC 13G/A - TFF Pharmaceuticals, Inc. (0001733413) (Subject)

    11/19/24 4:05:58 PM ET
    $TFFP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $A
    $AENZ
    $AEO
    $AGBA
    Financials

    Live finance-specific insights

    View All

    Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Buy Research Opinion on Zoom Communications (NASDAQ: ZM)

    NOTE TO EDITORS: The Following Is an Investment Opinion Issued by Spruce Point Capital Management Provides Evidence the Bear Thesis on Zoom Shares Does Not Hold Up to Scrutiny Believes Zoom's Transformation Into a Comprehensive, Value-Added, AI-First Platform Poised to Drive Deeper Enterprise Penetration is Underappreciated Demonstrates Zoom is Trading at a Massive Discount to Its Intrinsic Value, Particularly Considering Its Share Ownership in AI Leader Anthropic Identifies A Range of Cost Structure, Organizational Effectiveness, Capital Allocation Practices, and Corporate Governance Concerns For Zoom to Address Announces It Has Sent the Zoom Board of Directors a Letter Containin

    4/24/26 8:30:00 AM ET
    $ZM
    Computer Software: Programming Data Processing
    Technology

    Weight Watchers Schedules First Quarter 2026 Earnings Conference Call

    NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company") will release its results for the first quarter 2026 ended March 31, 2026, before market open on Thursday, May 7, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About Weight WatchersWeight Watchers is the global leader in science-backed weight management, offering an integrated support system built for the GLP-

    4/23/26 4:01:00 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Jack in the Box Announces Second Quarter 2026 Earnings Webcast

    Jack in the Box Inc. (NASDAQ:JACK) announces the following event: What: JACK Q2 2026 Earnings Webcast When: Wednesday, May 13, 2026 at 5 p.m. EDT Where: investors.jackinthebox.com How: Live webcast (web address above) Contact: Rachel Webb, Vice President of Finance and Investor Relations   (858) 522-4556     *This webcast event will be archived on the Jack in the Box investor relations website for replay. *Q2 2026 Earnings Release will go out after market close on Wednesday, May 13. About Jack in the Box Inc. Jack in the Box Inc. (NASDAQ:JACK), founded and headquarte

    4/23/26 7:30:00 AM ET
    $JACK
    Restaurants
    Consumer Discretionary